ELGA e-Medikation (R4) DRAFT
0.1.1 - ci-build
ELGA e-Medikation (R4) DRAFT
0.1.1 - ci-build
ELGA e-Medikation (R4) DRAFT, published by ELGA GmbH. This guide is not an authorized publication; it is the continuous build for version 0.1.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7Austria/ELGA-e-Medikation-R4/ and changes regularly. See the Directory of published versions
R5: Period over which the medication is to be taken (new): 2026-02-27 --> 2026-03-20
R5: Full representation of the dosage instructions (new):
1-0-1-0 täglich | 2 × täglich für 3 Wochen
status: Active
intent: Order
category: Planeintrag
reported: false
medication: Medication: form = Salbe
subject: Max Mustermann Male, DoB: 1900-01-01 ( Social Security number: 1234010100)
authoredOn: 2026-02-27 08:10:00+0000
requester: Practitioner Melanie Hausärztin
courseOfTherapyType: Short course (acute) therapy
| Extension | Sequence | Timing | Route |
| 1 | Morning, Evening, 2 per 1 day | Anwendung auf der Haut |
Generated Narrative: Medication #contained-medication-journey-02-magistral
form: Salbe
ingredient
item: Dexpanthenol
strength: 5 g (Details: UCUM codeg = 'g')/100 g (Details: UCUM codeg = 'g')
ingredient
item: Salbengrundlage
isActive: false
strength: 95 g/100 g